Market
Highlights:
According to MRFR analysis, the
global Life
Science Analytics Market Trends
is expected to register a CAGR of 11.91% during the forecast period of 2019
to 2025 and was valued at USD 19,165.22 million in 2018.
The growth of
the global life science analytics market can be contributed to growing pressure
to curb the healthcare expenditure, need for improved data standardization, and
increasing prevalence of chronic diseases.
Key Players:
·
Allscripts Healthcare
·
Cerner Corporation
·
CitiusTech Inc
·
Health Catalyst
·
Inovalon
·
McKesson Corporation
·
Saama Technologies
·
Optum
·
SCIOInspire
·
SAS Institute Inc
·
IBM
·
Oracle
·
IQVIA
Segmentation:
·
The global life science analytics market has
been segmented based on the type of analytics, application, component,
deployment model, and end user.
·
Based on the type of analytics, the global life
science analytics market has been segmented into predictive analytics,
descriptive analytics, and prescriptive analytics.
·
The global life science analytics market, based
on application, has been segmented into research & development,
pharmacovigilance, regulatory compliance, sales & marketing, and supply
chain optimization.
·
The global life science analytics market has
been segmented based on component, as software, services, and hardware.
·
The global life science analytics market has
been segmented, on the basis of deployment model, into on-premise and
cloud-based.
·
The market based on end user has been segmented
into hospitals & clinics, pharmaceutical, biotechnology & medical
device companies, and others. Hospitals & clinics segment held the largest
market share in 2018 as it helps to minimize the clinical errors and increases
healthcare productivity.
Regional
Analysis:
Americas: The largest regional market.
North America: The North American market for life
science analytics is growing due to the rising investments for technological
advancements in the region.
US: The increasing R&D expenditure in the life
sciences industry and rising adoption of information technology tools in the
life sciences industry is expected to drive the market growth in the US. In
2015, the US spent USD 30.5 billion to support research in the life sciences
industry. Thus, a similar trend of increasing R&D expenditure in the life
sciences industry is expected to boost market growth during the forecast
period.
Latin America: Increasing adoption of advanced
technologies in the life sciences analytics industry is anticipated to drive
the market growth.
Europe: Government initiatives to curb the healthcare
costs, presence of a large number of life science companies and greater
availability of life sciences software & services in the region are
expected to drive the market growth. For instance, Skane, a city in South
Sweden, has more than 300+ life science companies such as AstraZeneca, Getinge
and Nobel Biocare, among others. Thus, presence of such international players
increases the demand for life science analytical tools to streamline their
processes and thereby is expected to drive the market growth.
UK: Increasing adoption of big data in the life
sciences industry and high R&D expenditure in the life sciences sector in
the UK is expected to drive the market growth.
Germany: The rising number of clinical trials in
Germany, leading to the high adoption of analytical solutions for efficiently
carrying out the clinical trials, is expected to drive the market growth.
NOTE : Our team of researchers are studying Covid19 and its
impact on various industry verticals and wherever required we will be
considering covid19 footprints for a better analysis of markets and industries.
Cordially get in touch for more details.
Comments
Post a Comment